Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
4.970
-0.130 (-2.55%)
Mar 6, 2026, 4:00 PM EST - Market closed

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $566.15 million as of March 6, 2026. Its market cap has increased by 195.03% in one year.

Market Cap
566.15M
Enterprise Value
395.33M
1-Year Change
195.03%
Ranking
Category
Stock Price
$4.97

Market Cap Chart

Since April 19, 2007, Perspective Therapeutics's market cap has increased from $65.60M to $566.15M, an increase of 763.04%. That is a compound annual growth rate of 12.08%.

History

DateMarket Cap% Change
Mar 6, 2026369.50M80.77%
Dec 31, 2025204.40M-5.19%
Dec 31, 2024215.60M91.13%
Dec 29, 2023112.80M221.37%
Dec 30, 202235.10M-36.18%
Dec 31, 202155.00M39.95%
Dec 31, 202039.30M-6.65%
Dec 31, 201942.10M108.42%
Dec 31, 201820.20M-8.18%
Dec 29, 201722.00M-31.03%
Dec 30, 201631.90M-38.18%
Dec 31, 201551.60M-35.58%
Dec 31, 201480.10M317.19%
Dec 31, 201319.20M-28.89%
Dec 31, 201227.00M41.36%
Dec 30, 201119.10M-28.20%
Dec 31, 201026.60M30.39%
Dec 31, 200920.40M343.48%
Dec 31, 20084.60M-90.09%
Dec 31, 200746.40M-29.27%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CeriBell 673.40M
Tactile Systems Technology 659.93M
Avanos Medical 641.28M
SI-BONE 621.41M
Bioventus 609.49M
Cytek Biosciences 563.05M
Varex Imaging 527.35M
BrainsWay 508.31M
Market Cap Rankings